General Information

MaintermZINC SULFIDE
CAS Reg.No.(or other ID)1314-98-3
Regnum 175.105
177.2600
178.3570
178.3297

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID14821
IUPAC Namesulfanylidenezinc
InChIInChI=1S/S.Zn
InChI KeyWGPCGCOKHWGKJJ-UHFFFAOYSA-N
Canonical SMILESS=[Zn]
Molecular FormulaZnS
Wikipediazinc sulfide

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight97.44
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count0
Complexity2.0
CACTVS Substructure Key Fingerprint A A A D c Q A A A A B A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area32.1
Monoisotopic Mass95.901
Exact Mass95.901
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count2
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.9786
Human Intestinal AbsorptionHIA+0.9946
Caco-2 PermeabilityCaco2+0.6224
P-glycoprotein SubstrateNon-substrate0.9080
P-glycoprotein InhibitorNon-inhibitor0.9531
Non-inhibitor0.9963
Renal Organic Cation TransporterNon-inhibitor0.9256
Distribution
Subcellular localizationLysosome0.5883
Metabolism
CYP450 2C9 SubstrateNon-substrate0.8623
CYP450 2D6 SubstrateNon-substrate0.8451
CYP450 3A4 SubstrateNon-substrate0.8077
CYP450 1A2 InhibitorNon-inhibitor0.7198
CYP450 2C9 InhibitorNon-inhibitor0.7485
CYP450 2D6 InhibitorNon-inhibitor0.9188
CYP450 2C19 InhibitorNon-inhibitor0.8081
CYP450 3A4 InhibitorNon-inhibitor0.8699
CYP Inhibitory PromiscuityLow CYP Inhibitory Promiscuity0.7396
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.9330
Non-inhibitor0.9694
AMES ToxicityNon AMES toxic0.8363
CarcinogensCarcinogens 0.6862
Fish ToxicityHigh FHMT0.6347
Tetrahymena Pyriformis ToxicityHigh TPT0.5348
Honey Bee ToxicityHigh HBT0.8798
BiodegradationNot ready biodegradable0.9530
Acute Oral ToxicityIII0.6576
Carcinogenicity (Three-class)Non-required0.5694

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-1.6232LogS
Caco-2 Permeability1.5681LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity2.2807LD50, mol/kg
Fish Toxicity1.5493pLC50, mg/L
Tetrahymena Pyriformis Toxicity-0.1465pIGC50, ug/L

From admetSAR


Toxicity Profile

Route of ExposureInhalation ; oral ; dermal
Mechanism of ToxicityAnaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc.
MetabolismZinc can enter the body through the lungs, skin, and gastrointestinal tract. Intestinal absorption of zinc is controlled by zinc carrier protein CRIP. Zinc also binds to metallothioneins, which help prevent absorption of excess zinc. Zinc is widely distributed and found in all tissues and tissues fluids, concentrating in the liver, gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas. In the bloodstream zinc is found bound to carbonic anhydrase in erythrocytes, as well as bound to albumin, _2-macroglobulin, and amino acids in the the plasma. Albumin and amino acid bound zinc can diffuse across tissue membranes. Zinc is excreted in the urine and faeces.
Toxicity ValuesLD50: >2000 mg/kg (Oral, Rat) LD50: >2000 mg/kg (Dermal, Rat) LC50: 5040 mg/m3 (Inhalation, Rat)
Lethal DoseNone
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Minimum Risk LevelIntermediate Oral: 0.3 mg/kg/day Chronic Oral: 0.3 mg/kg/day
Health EffectsChronic exposure to zinc causes anemia, atazia, lethargy, and decreases the level of good cholesterol in the body. It is also believed to cause pancreatic and reproductive damage. (L49)
TreatmentZinc poisoning is treated symptomatically, often by administering fluids such as water or milk, or with gastric lavage.
Reference
  1. Vonk WI, Klomp LW: Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. Biochem Soc Trans. 2008 Dec;36(Pt 6):1322-8. doi: 10.1042/BST0361322.[19021549 ]

From T3DB


Taxonomic Classification

KingdomInorganic compounds
SuperclassMixed metal/non-metal compounds
ClassTransition metal organides
SubclassTransition metal sulfides
Intermediate Tree NodesNot available
Direct ParentTransition metal sulfides
Alternative Parents
Molecular FrameworkNot available
SubstituentsTransition metal sulfide - Inorganic sulfide - Inorganic salt
DescriptionThis compound belongs to the class of inorganic compounds known as transition metal sulfides. These are inorganic compounds containing a sulfur atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen is a transition metal.

From ClassyFire


Targets

General Function:
Zinc ion binding
Specific Function:
Destroys radicals which are normally produced within the cells and which are toxic to biological systems.
Gene Name:
SOD1
Uniprot ID:
P00441
Molecular Weight:
15935.685 Da
References
  1. Vonk WI, Klomp LW: Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis. Biochem Soc Trans. 2008 Dec;36(Pt 6):1322-8. doi: 10.1042/BST0361322. [19021549 ]

From T3DB